Search clinical trials for: MOD-4023

Total 1584 results

OPKO Health, Inc.

Terminated

A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency

Adult Growth Hormone Deficiency

Israel
OPKO Health, Inc.
WCCT Global

Completed

Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers

Growth Hormone Deficiency

United States
OPKO Health, Inc.

Completed

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Growth Hormone Deficiency (GHD)

United States, Belarus, Greece, Hungary, Russian Federation, Ukraine
OPKO Health, Inc.

Completed

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Greece, Hungary, Slovakia
OPKO Health, Inc.

Active, not recruiting

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Israel, United States, India, Korea, Republic of, Australia, Taiwan, Spain, Argentina, Belarus, Bulgaria, Canada, Colombia, Georgia, Greece, Mexico, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
OPKO Health, Inc.
Tel-Aviv Sourasky Medical Center

Completed

MOD-4023 Study in Healthy Male Volunteers

Healthy

Israel
OPKO Health, Inc.

Completed

MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)

Adult Growth Hormone Deficiency

Czechia, Hungary, Israel, Serbia, Slovakia, Slovenia
OPKO Health, Inc.

Completed

Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency

Growth Hormone Deficiency

Japan
Gloucestershire Hospitals NHS Foundation Trust

Unknown

Intracranial Pressure vs Percentage Body Fat

Intracranial Pressure

United Kingdom
Johns Hopkins University
National Institute of Mental Health (NIMH)

Completed

Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation

Severe Mood Dysregulation

United States
Asan Medical Center

Terminated

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015) (ATLAS2015)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Korea, Republic of
Novo Nordisk A/S

Completed

First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

Diabetes Mellitus, Type 2

United States
Azura Ophthalmics
Syneos Health; Cliantha Research

Completed

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Dry Eye | Meibomian Gland Dysfunction

Canada, Australia, New Zealand
OPKO Health, Inc.
Tel-Aviv Sourasky Medical Center

Completed

A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects

Obesity

Israel
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Unknown

Mid-HDF Randomized Controlled Study on Outcome (MILESTONE)

End Stage Renal Disease

Spain, France, Italy, Belgium
University of Kansas Medical Center

Terminated

MOD Diet in Gestational Diabetes Mellitus (MOD)

Gestational Diabetes

United States
University of Alberta

Recruiting

Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes

Type 1 Diabetes

Canada
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States
San Antonio Military Medical Center

Completed

Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

Fatty Liver

United States
University of Alabama at Birmingham
Salk Institute for Biological Studies; Wright State University

Completed

Precision High-Intensity Training Through Epigenetics (PHITE) (PHITE)

Healthy

United States
Cairo University

Completed

Clinical Performance of the Indirect Resin Composite Restorations in Endodontically Treated Teeth

Endodontically Treated Teeth

Egypt
OPKO Health, Inc.

Completed

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Hemophilia A or B With Inhibitors

Israel
Promentis Pharmaceuticals, Inc.

Completed

A Study in Patients With Trichotillomania (TTM)

Trichotillomania

United States
Biotie Therapies Corp.

Completed

BTT-1023 in Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Pepperdine University

Recruiting

The Effect of Beetroot Juice Supplementation Dose on Neuromuscular Performance During Resistance Exercise

High Nitrate Dose | Moderate Nitrate Dose | Low Nitrate Dose | Nitrate-depleted Dose

United States
Lawson Health Research Institute

Completed

Modulation of Hyperinflammation in COVID-19

COVID-19 | SARS

Canada
OPKO Health, Inc.

Completed

A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Hemophilia A | Hemophilia B

United States
University Hospital, Gentofte, Copenhagen
Sygekassernes Helsefond; Apotekerfonden af 1991; Indenrigs- og sundhedsministeriet

Unknown

Treatment of Chronic Low Back Pain: A Trial Comparing Traditional Back School and Individual Therapist-Assisted Exercise

Chronic Low Back Pain

Denmark
Reata, a wholly owned subsidiary of Biogen

Withdrawn

Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

Malignant Melanoma
Kainos Medicine Inc.

Completed

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Human Immunodeficiency Virus

Korea, Republic of
Universitätsklinikum Hamburg-Eppendorf
German Federal Ministry of Education and Research

Completed

Enhancing Participation of Chronic Stroke Patients by Constraint Induced Movement Therapy (HOMECIMT) (HOMECIMT)

Stroke

Germany
Gastrovital

Completed

Bar and Ball Joint Overdentures Surface Roughness and Microbial Adherence

Adhesiveness
Promentis Pharmaceuticals, Inc.
Celerion

Completed

Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers

Healthy

United States
National Institute on Drug Abuse (NIDA)
Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences...

Not yet recruiting

SXC-2023 Cocaine Interaction Study

Cocaine Use Disorder

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease

Digestive System Disease

United States
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults (GLYDE)

PreDiabetes | Aging

United States
Children's Hospital of Philadelphia
Minnesota HealthSolutions

Completed

Distracted Driving App Study for Teens and Parents/Caregivers (IDD)

Distracted Driving

United States
Kyowa Kirin Co., Ltd.

Terminated

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes | Chronic Kidney Disease

Japan
M.D. Anderson Cancer Center
Reata Pharmaceuticals, Inc.

Completed

RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies

Solid Tumors | Lymphoid Malignancies

United States
Promentis Pharmaceuticals, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023

Healthy Volunteers

United States
Ono Pharmaceutical Co. Ltd

Completed

A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

Healthy Adult Male Subjects

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Healthy Adult Subjects

United Kingdom
Ono Pharmaceutical Co. Ltd

Terminated

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Healthy Adult Subjects

United Kingdom
Sarepta Therapeutics, Inc.

Terminated

An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease

West Nile Fever
Sarepta Therapeutics, Inc.

Completed

Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020

West Nile Virus

United States
Reata, a wholly owned subsidiary of Biogen

Terminated

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

Liver Disease

United States
University Hospital Schleswig-Holstein

Recruiting

Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes

Safety Issues | Pharmacokinetic

Germany
PharmAbcine
C&R Research, Inc.

Recruiting

Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

Korea, Republic of
Amgen

Completed

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject

Chronic Pain
Amgen

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain

Osteoarthritis

Search clinical trials for: MOD-4023

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations